ClinicalTrials.Veeva

Menu

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease (ENGAGE-PD)

J

James Liao

Status and phase

Enrolling
Phase 1

Conditions

Gait Disorders, Neurologic
Subthalamic Nucleus
Disease Progression
Parkinson Disease
Deep Brain Stimulation
Accidental Fall

Treatments

Device: Low-Frequency-Only Stimulation
Drug: ON Dopaminergic Medication
Device: High-Frequency-Only Stimulation
Device: Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation
Device: Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation
Device: Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation
Drug: OFF Dopaminergic Medication
Device: Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).

Full description

Postural instability, gait impairment, and falls are among the greatest unmet needs in Parkinson disease (PD). A single fall can be catastrophic, and impairments that limit mobility lead to social isolation or depression, and adversely affect bone and cardiovascular health. Unfortunately, postural instability and gait disorders are refractory to current pharmacological and surgical treatments, including deep brain stimulation (DBS). This project will directly address this pressing need. We will recruit participants to perform a gait task, using a new, alternating DBS frequency paradigm, while body movements and neural signals are recorded. The findings will lead to improved therapies to address these symptoms in the future.

Enrollment

12 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bilateral STN DBS for PD
  • Medtronic Percept PC implanted DBS battery/pulse generator/recording system
  • Presence of balance and/or walking impairment and/or freezing of gait
  • Can walk without assistance, OFF meds, based on yes/no verbal response

Exclusion criteria

  • Severity of gait impairment should not require dependency to walker or cane
  • Cannot tolerate monopolar stimulation at either of the two middle electrode contacts (prerequisite for the recording mode of the DBS) at high frequency (130 Hz) or low frequency (60 Hz).
  • Concomitant conditions that may affect significantly the evaluation of balance or gait, including orthopedic, rheumatologic or other neurological diseases
  • Contraindication to physical therapy
  • Age < 21
  • Diagnosis of dementia
  • Not agreeable to having video taken of entire research visit

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Alternating-Frequency DBS
Experimental group
Description:
In this single-arm study, all participants will receive all interventions in a crossover fashion.
Treatment:
Drug: OFF Dopaminergic Medication
Device: Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation
Device: Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation
Device: Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation
Device: Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation
Drug: ON Dopaminergic Medication
Device: High-Frequency-Only Stimulation
Device: Low-Frequency-Only Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

James Liao, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems